As the digital health market continues to expand—projected to grow from nearly $250 billion in 2023 to over $815 billion by 2030—it’s essential to reassess how we measure its success. The prevailing focus on ROI has driven much of this sector's growth. In fact, a recent survey revealed that 94% of investors prioritize ROI over clinical evidence when evaluating digital health tools. The data backs it up; 82% of healthcare and life sciences companies note significant or moderate revenue increases
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
AMA Issues CPT Code for Eko Health’s AI-Powered Cardiac Screening Tool
What You Should Know:
- Eko Health, a pioneer in applying artificial intelligence for early detection of heart and lung diseases, today announced the issuance of a Category III Current Procedural Terminology (CPT) code by the American Medical Association (AMA) for its SENSORA™ platform.
-The newly issued Category III CPT code will be effective on July 1, 2025, and is the first step to coverage and reimbursement for SENSORA™, bringing advanced heart disease detection to clinicians across
Read More
The Future of Healthcare: AI-Powered Patient Experiences
As the AI market in healthcare soars to a projected $187.95 billion by 2030, the transformative impact of technology on patient care becomes increasingly evident. AI is at the forefront of revolutionizing healthcare, blending data analytics, user-centric innovations, and advanced technology to reshape traditional health management and personalize the patient experience. This rapid evolution underscores a critical shift in healthcare dynamics by creating a patient experience that mirrors what
Read More
Helix Unveils AI Model Predicting Semaglutide Weight Loss Response at ASHG 2024
What You Should Know:
- Helix, a leader in population genomics and precision health, presented groundbreaking research at the American Society of Human Genetics (ASHG) 2024 Annual Meeting.
- The highlight was a novel AI-powered model that predicts the 12-month weight loss response of semaglutide, a popular medication for obesity and type 2 diabetes, in diverse populations.
Predicting Weight Loss with Precision
Helix researchers developed an integrated polygenic risk score
Read More
Primary Care Provider Forward Closes Its Doors
What You Should Know:
- Forward, a technology-driven preventive primary care provider, has announced the immediate closure of all its locations and the shutdown of its mobile app.
- The sudden announcement leaves members scrambling to find new providers and access their medical records.
Immediate Cessation of Services
Effective immediately, Forward has ceased all operations, including:
Employee Layoffs: All 200 Forward employees will be laid off. Closure of
Read More
NVentures Invests in Genesis Therapeutics’ AI Platform for Drug Development
What You Should Know:
- Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients, announced today a further equity investment from NVentures, NVIDIA’s venture capital arm.
- This investment is in addition to NVentures’ participation in the company’s $200 million Series B financing in August 2023.
Genesis Therapeutics Partners with NVIDIA to Advance AI-Driven Drug Discovery
Genesis Therapeutics, an AI-focused
Read More
Medeloop Raises $15.5M for AI-Driven Medical Research Platform
What You Should Know:
- Medeloop, a pioneering medical research platform, has secured $15.5M in Series A funding to further its mission of revolutionizing medical research through artificial intelligence (AI).
- The funding round was led by Inovia Capital, with participation from Icon Ventures and support from existing investors General Catalyst and Maven Ventures.
AI-Powered Platform Streamlines Research
Founded by AI experts at Stanford, Medeloop partners with
Read More
Bluespine Raises $7.2M to Combat Medical Overbilling with AI
What You Should Know:
- Bluespine, an AI-driven claims cost reduction platform for self-insured employers, has secured $7.2M in seed funding to address the pervasive issue of medical overbilling in the US healthcare system led by Team8.
- The seed funding will accelerate Bluespine's adoption by US employers and brokers, as well as support further research and development.
Tackling the Healthcare Cost Crisis
Bluespine was co-founded by a team of technology experts with deep
Read More
NEC X Invests in GPx to Advance AI-Driven Chronic Disease Monitoring
What You Should Know:
- NEC X, the Silicon Valley venture studio backed by NEC’s portfolio of advanced technologies and global businesses, today announced a new investment in General Prognostics Inc.
- (GPx), a fast-growing MedTech startup revolutionizing chronic disease monitoring and management.
NEC X Invests in GPx to Advance Remote Blood Monitoring Solution for Heart Failure Patients
NEC X has invested in GPx as part of its strategic effort to foster healthcare innovation and
Read More
Ubie and PatientsLikeMe Partner to Improve Patient Journeys with AI
What You Should Know:
- Ubie, a global healthcare AI platform that guides patients to better interactions with providers and life sciences, and PatientsLikeMe (PLM), the leading integrated patient engagement, activation and health tracking platform that empowers over 850,000 patients to navigate their health journeys, today announced a partnership to empower patients with serious illnesses throughout their healthcare journey.
- By integrating Ubie’s AI-powered Symptom Checker with the
Read More
